Most recently, the company leveraged its core technology and 13 years of healthcare scheduling expertise to introduce Zocdoc Vaccine Scheduler. By aggregating millions of in-person and video visit appointments across a nationwide provider network, Zocdoc is distinctly positioned to become the front door to healthcare. The company successfully expanded into telehealth, making it a rare digital health platform that supports hybrid care: both physical and virtual care services. However, as the pandemic dramatically accelerated the adoption of telehealth, Zocdoc rapidly adapted its marketplace. Zocdoc has long been the leader in online scheduling for in-person doctors' appointments. The company will use the capital to further propel its rapid growth, deepening its investments in sales and marketing, and expanding the products available through its platform. Today, Zocdoc is profitable and on track to accelerate its pre-pandemic growth trajectory. Zocdoc grew revenue by more than 35% year-over-year before the pandemic, and had year-over-year growth in 2020 despite COVID-19's disruption. This follows a momentous year for the company, characterized by a successful transition to a profitable variable revenue model which has led to accelerating growth. NEW YORK - Zocdoc, the country's leading digital healthcare marketplace, today announced $150 million in growth financing from Francisco Partners, a leading global investment firm that specializes in partnering with technology businesses.

Zocdoc vaccine